Global Primary Ciliary Dyskinesia Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 19533

Primary ciliary dyskinesia (PCD), also called immotile ciliary syndrome or Kartagener syndrome, is a rare, ciliopathic, autosomal recessive genetic disorder that causes defects in the action of cilia lining the respiratory tract (lower and upper, sinuses, Eustachian tube, middle ear), fallopian tube, and flagella of sperm cells.
There no standardized effective treatment strategies for the condition. Severe fatal respiratory failure can develop; long-term treatment with macrolides such as clarithromycin, erythromycin and azithromycin has been empirically applied for the treatment of primary ciliary dyskinesia in Japan, though controversial due to the effects of the medications.
In 2018, the global Primary Ciliary Dyskinesia market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Primary Ciliary Dyskinesia status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Primary Ciliary Dyskinesia development in United States, Europe and China.

The key players covered in this study
AstraZeneca
Boehringer Ingelheim
Novartis
Teva
Bayer
Rotech Healthcare
Pfizer
...

Market segment by Type, the product can be split into
Genetic Testing
Electron Microscopy

Market segment by Application, split into
Hospitals & Clinics
Research Centers

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Primary Ciliary Dyskinesia status, future forecast, growth opportunity, key market and key players.
To present the Primary Ciliary Dyskinesia development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Primary Ciliary Dyskinesia are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Primary Ciliary Dyskinesia Market Size Growth Rate by Type (2014-2025)
1.4.2 Genetic Testing
1.4.3 Electron Microscopy
1.5 Market by Application
1.5.1 Global Primary Ciliary Dyskinesia Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Research Centers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Primary Ciliary Dyskinesia Market Size
2.2 Primary Ciliary Dyskinesia Growth Trends by Regions
2.2.1 Primary Ciliary Dyskinesia Market Size by Regions (2014-2025)
2.2.2 Primary Ciliary Dyskinesia Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Primary Ciliary Dyskinesia Market Size by Manufacturers
3.1.1 Global Primary Ciliary Dyskinesia Revenue by Manufacturers (2014-2019)
3.1.2 Global Primary Ciliary Dyskinesia Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Primary Ciliary Dyskinesia Market Concentration Ratio (CR5 and HHI)
3.2 Primary Ciliary Dyskinesia Key Players Head office and Area Served
3.3 Key Players Primary Ciliary Dyskinesia Product/Solution/Service
3.4 Date of Enter into Primary Ciliary Dyskinesia Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Primary Ciliary Dyskinesia Market Size by Type (2014-2019)
4.2 Global Primary Ciliary Dyskinesia Market Size by Application (2014-2019)

5 United States
5.1 United States Primary Ciliary Dyskinesia Market Size (2014-2019)
5.2 Primary Ciliary Dyskinesia Key Players in United States
5.3 United States Primary Ciliary Dyskinesia Market Size by Type
5.4 United States Primary Ciliary Dyskinesia Market Size by Application

6 Europe
6.1 Europe Primary Ciliary Dyskinesia Market Size (2014-2019)
6.2 Primary Ciliary Dyskinesia Key Players in Europe
6.3 Europe Primary Ciliary Dyskinesia Market Size by Type
6.4 Europe Primary Ciliary Dyskinesia Market Size by Application

7 China
7.1 China Primary Ciliary Dyskinesia Market Size (2014-2019)
7.2 Primary Ciliary Dyskinesia Key Players in China
7.3 China Primary Ciliary Dyskinesia Market Size by Type
7.4 China Primary Ciliary Dyskinesia Market Size by Application

8 Japan
8.1 Japan Primary Ciliary Dyskinesia Market Size (2014-2019)
8.2 Primary Ciliary Dyskinesia Key Players in Japan
8.3 Japan Primary Ciliary Dyskinesia Market Size by Type
8.4 Japan Primary Ciliary Dyskinesia Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Primary Ciliary Dyskinesia Market Size (2014-2019)
9.2 Primary Ciliary Dyskinesia Key Players in Southeast Asia
9.3 Southeast Asia Primary Ciliary Dyskinesia Market Size by Type
9.4 Southeast Asia Primary Ciliary Dyskinesia Market Size by Application

10 India
10.1 India Primary Ciliary Dyskinesia Market Size (2014-2019)
10.2 Primary Ciliary Dyskinesia Key Players in India
10.3 India Primary Ciliary Dyskinesia Market Size by Type
10.4 India Primary Ciliary Dyskinesia Market Size by Application

11 Central & South America
11.1 Central & South America Primary Ciliary Dyskinesia Market Size (2014-2019)
11.2 Primary Ciliary Dyskinesia Key Players in Central & South America
11.3 Central & South America Primary Ciliary Dyskinesia Market Size by Type
11.4 Central & South America Primary Ciliary Dyskinesia Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Primary Ciliary Dyskinesia Introduction
12.1.4 AstraZeneca Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 Boehringer Ingelheim
12.2.1 Boehringer Ingelheim Company Details
12.2.2 Company Description and Business Overview
12.2.3 Primary Ciliary Dyskinesia Introduction
12.2.4 Boehringer Ingelheim Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.2.5 Boehringer Ingelheim Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Primary Ciliary Dyskinesia Introduction
12.3.4 Novartis Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Teva
12.4.1 Teva Company Details
12.4.2 Company Description and Business Overview
12.4.3 Primary Ciliary Dyskinesia Introduction
12.4.4 Teva Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.4.5 Teva Recent Development
12.5 Bayer
12.5.1 Bayer Company Details
12.5.2 Company Description and Business Overview
12.5.3 Primary Ciliary Dyskinesia Introduction
12.5.4 Bayer Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.5.5 Bayer Recent Development
12.6 Rotech Healthcare
12.6.1 Rotech Healthcare Company Details
12.6.2 Company Description and Business Overview
12.6.3 Primary Ciliary Dyskinesia Introduction
12.6.4 Rotech Healthcare Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.6.5 Rotech Healthcare Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Primary Ciliary Dyskinesia Introduction
12.7.4 Pfizer Revenue in Primary Ciliary Dyskinesia Business (2014-2019)
12.7.5 Pfizer Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details